Global Markets Direct Research

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.
Global Markets Direct Research
 

List of reports from Global Markets Direct Research

1  2    4    6  7  8  9  10  
Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... targeted pipeline therapeutics. The report provides comprehensive information on the Histone Deacetylase 1 (EC 3.5.1.98), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 3,500
Cathepsin S (EC 3.4.22.27) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... The report provides comprehensive information on the Cathepsin S (EC 3.4.22.27), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also ...  |  read more...
USD 3,500
Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... depth analysis on Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.) targeted pipeline therapeutics. The report provides comprehensive information on the Collagenase 3 (Matrix Metalloproteinase-13 or MMP13 or EC 3.4.24.), targeted therapeutics, complete with ...  |  read more...
USD 3,500
Medulloblastoma - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Medulloblastoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Streptococcal Pneumonia - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... therapeutics under development for Streptococcal Pneumonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... I (MPS I) (Hurler Syndrome ) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Ignyta, Inc. - Product Pipeline Review - 2016
6/8/2016 | published by: Global Markets Direct
... provides comprehensive information on the therapeutics under development by Ignyta, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers ...  |  read more...
USD 1,500
Liposarcoma - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Liposarcoma , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its ...  |  read more...
USD 2,000
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections, complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Poliomyelitis - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Poliomyelitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pituitary ACTH Hypersecretion (Cushing Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Hypertension - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Retinopathy - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Retinopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Myocardial Fibrosis - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... therapeutics under development for Myocardial Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... III (MPS III) (Sanfilippo Syndrome ) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ), complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... the Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency), complete with analysis by stage ...  |  read more...
USD 2,000
Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Sicca Syndrome (Sjogren), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Hyperglycemia - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Hyperglycemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Toxoplasmosis - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Toxoplasmosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Nanotherapeutics, Inc. - Product Pipeline Review - 2016
6/8/2016 | published by: Global Markets Direct
... provides comprehensive information on the therapeutics under development by Nanotherapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers ...  |  read more...
USD 1,500
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016
6/8/2016 | published by: Global Markets Direct
... focus. The report provides comprehensive information on the therapeutics under development by Sangamo BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Herpes Simplex Virus (HSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!